Investors should buy SkinBio Therapeutics (SBTX:AIM) as it prepares to launch a new product which could generate tens of millions of pounds in fresh revenue for the business.The company has developed a proprietary technology platform which harnesses the human microbiome to improve skin health and access the growing market for probiotic products.On 26 May the company reported impressive results...

The shares of 27 AIM companies have doubled or better so far in 2018. For those that don't know, AIM is the Alternative Investment Market, the junior trading platform of the stock market designed to nurture small, growth companies.While the rewards can be substantial, so are the risks, a point illustrated by Bahamas Petroleum (BPC:AIM) today. Its stock tanked more than 60% on Friday 24 August...

By the Shares teamInvestors are spoiled for choice when it comes to small cap stocks with exciting events. As a taster for what's to come in 2018, we've scoured the markets to look for some of the most interesting activities.Read on to discover 19 stocks either expecting big news in the very near future or ones which are in the middle of developments which could have a big impact on their...

Retail investors are missing out on significant gains enjoyed by institutional investors who are able to take part in IPOs (initial public offerings), according to analysis by Shares and AJ Bell.We've calculated the share price performance of every IPO this year and compared the gains between buying at the IPO offer price and buying at the first available price in the market on day one.The...